Short peptides like GRP, bombesin and their analogues have been linked to radioactive isotopes as a means to label GRPR in prostate cancer and potentially to treat prostate cancer10, 11, 12, 13, 43, 44, 45, 46, 47, 48. This evidence concerns the gene GRP and Familial prostate cancer.